Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases


Sipahi O. R., Kahraman H., Mermer S., Pullukcu H., Tasbakan M., Arda B., ...More

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol.23, pp.16-19, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23
  • Publication Date: 2014
  • Doi Number: 10.1016/j.ijid.2014.01.027
  • Journal Name: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.16-19
  • Keywords: Spondylitis, Nosocomial, Hospital-acquired, Healthcare-associated infection, Acinetobacter baumannii, Carbapenem-resistant, RESISTANT STAPHYLOCOCCUS-AUREUS, OSTEOMYELITIS, MODEL
  • Eskisehir Osmangazi University Affiliated: No

Abstract

Background: Tigecycline is a relatively new glycylcycline antimicrobial, active in vitro against a variety of Gram-positive and Gram-negative organisms. In this study we evaluated the outcomes of spondylodiscitis cases treated with tigecycline-including therapies retrospectively.